Literature DB >> 20515800

Pediatric HIV infection and bone health: an emerging challenge.

Stefano Mora1, Ilaria Zamproni, Gianvincenzo Zuccotti, Alessandra Vigano.   

Abstract

The available data indicate that HIV-infected children and adolescents have reduced bone mass compared to healthy peers. The increased survival due to the control of HIV infection by potent antiretroviral treatment, exposes patients to the achievement of a reduced peak bone mass and to an increased fracture risk during adult life. Reduced bone mass in HIV-infected children is the result of altered bone metabolism, showing significantly increased bone resorption rate. Both infection per se and the use of certain antiretroviral compounds seem to contribute to the altered metabolism. Preventative measures to improve bone health are thus necessary in all young patients that exhibit low bone mass measurements and altered bone metabolism.

Entities:  

Mesh:

Year:  2010        PMID: 20515800     DOI: 10.2741/e188

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  3 in total

1.  Sclerostin and DKK-1: two important regulators of bone metabolism in HIV-infected youths.

Authors:  Stefano Mora; Maria Puzzovio; Vania Giacomet; Valentina Fabiano; Katia Maruca; Silvia Capelli; Pilar Nannini; Giovanni Lombardi; Gian Vincenzo Zuccotti
Journal:  Endocrine       Date:  2015-01-18       Impact factor: 3.633

2.  Long-term body composition and metabolic changes in HIV-infected children switched from stavudine to tenofovir and from protease inhibitors to efavirenz.

Authors:  Valentina Fabiano; Vania Giacomet; Alessandra Viganò; Giorgio Bedogni; Sara Stucchi; Lucia Cococcioni; Stefano Mora; Gian Vincenzo Zuccotti
Journal:  Eur J Pediatr       Date:  2013-05-01       Impact factor: 3.183

3.  Impact of HIV-1 Infection and Antiretroviral Therapy on Bone Homeostasis and Mineral Density in Vertically Infected Patients.

Authors:  D Donà; E Mozzo; D Luise; R Lundin; A Padoan; O Rampon; C Giaquinto
Journal:  J Osteoporos       Date:  2019-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.